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Abstract  
This work examines the quality of the cost methods used to derive patient level costs 
in 45 economic evaluations conducted alongside randomised controlled trials. The 
perspective of the cost analysis, the methods used to determine quantities and values 
of resources and how the cost data were reported are examined. The reported costing 
methods were found to be of poor quality, highlighting the need for greater rigour. 
Researchers to date appear more concerned with whether cost data have been 
subjected to the appropriate statistical analysis. For the results of clinical studies to be 
valid both cost methods and the methods used for the statistical analysis of cost data 
should be of a high quality. Copyright © 2002 John Wiley & Sons, Ltd.  
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